Anagen effluvium is a rare adverse effect of methotrexate therapy, generally associated with high-dose regimens. We report a 12-year-old girl who developed abrupt hair loss 1 week after inadvertently taking methotrexate 15 mg daily for five consecutive days (total 75 mg), without other signs of systemic toxicity. Trichoscopic examination and trichogram findings confirmed methotrexate-induced anagen effluvium, and spontaneous hair regrowth occurred after 2 months. This case underlines the importance of careful methotrexate dose monitoring and awareness that methotrexate toxicity can be associated with anagen effluvium even in the absence of other signs of toxicity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pde.15927 | DOI Listing |
Pediatr Dermatol
March 2025
Department of Dermatology, Ankara Etlik City Hospital, Ankara, Turkey.
Anagen effluvium is a rare adverse effect of methotrexate therapy, generally associated with high-dose regimens. We report a 12-year-old girl who developed abrupt hair loss 1 week after inadvertently taking methotrexate 15 mg daily for five consecutive days (total 75 mg), without other signs of systemic toxicity. Trichoscopic examination and trichogram findings confirmed methotrexate-induced anagen effluvium, and spontaneous hair regrowth occurred after 2 months.
View Article and Find Full Text PDFInt J Risk Saf Med
January 2025
Department of Dermatology and Venereology, All India Institute of Medical Sciences, Bhubaneshwar, India.
Background: Anagen effluvium is described as abrupt hair loss during the anagen phase due to reduced follicular mitotic activity. Chemotherapeutic medicines, toxic metals, and sporadically bismuth, levodopa, colchicine, and cyclosporine are often implicated in etiology. Plica polonica is a rare disorder that develops when the scalp hair mats completely and abruptly, resulting in an extended stiff mass of hair that resembles dreadlocks.
View Article and Find Full Text PDFInt J Dermatol
February 2025
Trichology Clinic, Dermatology Department, Hospital General Manuel Gea González, Mexico City, Mexico.
Skin Appendage Disord
February 2025
Department of Dermatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Introduction: Chronic telogen effluvium (TE) and androgenetic alopecia represent two prevalent forms of hair loss that can significantly impact individuals' quality of life. Insufficiency of essential micronutrients has been associated with hair loss. The objective of this study was to evaluate the safety and efficacy of an oral supplement containing l-Cystine, , , , vitamins, and micronutrients in chronic TE (CTE) and androgenetic alopecia (AGA).
View Article and Find Full Text PDFExp Dermatol
October 2024
Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!